skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: PXT recently announced production that was below analyst expectations, and the stock is down quite a bit today. In add-on, their forecast for 2024 is also light, although a bit of an increase over 2023. I'm surprised, as i bought this one for its strong growth prospects. What do you think of this company going forward? Can they still increase the dividend? buy back stock?
Read Answer Asked by arnold on January 16, 2024
Q: Hi Team,
Currently, what's your thoughts on the Trade Desk? I have been reading how this year might be a big one for advertising. Do you expect them to turn around after being weak since their last earnings miss? Is it worth holding or is there better opportunities I should be buying with the funds instead? My shres are held inside a TFSA with a considerable % gain. Thanks

Shane.
Read Answer Asked by Shane on January 16, 2024
Q: Robotics were a big part of the latest CES show in Las Vegas.

I would like to know what your best investment ideas to play this secular trend. I believe with the increased cost of labour this trend will only accelerate.
I am looking for your best stocks or ETF ideas to put in an RRSP to profit from this assumption.

Thanks for all your ideas and insights.
Read Answer Asked by Thomas on January 16, 2024
Q: Do you think long term investors will eventually be rewarded? Their software is installed in 54% of cars coming off assembly lines worldwide, have announced some big partnerships since beginning of December, are expanding into the fitness industry, yet share price really hasn’t moved.
Thanks for your insight.
Read Answer Asked by Curtis on January 16, 2024
Q: I hold approximate 5% of my portfolio in Crypto stocks (ETF's and Mining companies). With the SEC's approval of ETF's should I consider selling a few of the above and purchasing one of these new ETF's and if so, which one would you recommend. Thanks
Read Answer Asked by Marjorie on January 16, 2024
Q: ESSA Pharma is just one example of an exciting pharma in a topically interesting (prostate cancer, aging population…) area but with impenetrable valuation characteristics. Can you say whether this stock’s prospects are worth its price? Are there other early-stage pharmas you like?
Read Answer Asked by David on January 16, 2024
Q: This is NOT a question but a comment!

I of course benefit from the words of wisdom of Peter and his team. Peter with his extensive experience and having worked with some giants in this field like Eric Sprott has so much to share.
However I also benefit from fellow subscribers' questions/comments. Today (15-01-2024) Dave mentioned about Don Coxe in his question about LB.TO. It brought fond memories of Don Coxe whose columns on FP (previous iteration) I used enjoy. Arguably one of the most elegant financial writers whose USD:EURO ratio was very popular once. I presume he has retired. Please do share the link if Don Coxe is still writing columns anywhere!
Read Answer Asked by Savalai on January 16, 2024
Q: Hi,

I would like to purchase a large, dividend paying US stock that has some potential for future growth (or is currently undervalued) in my RRSP. Could you provide some suggestions?

Thank you,
Evan
Read Answer Asked by Evan on January 16, 2024
Q: Everyone, we have heard many people and the investment community identify and comment on magnificent seven in the US. What are the magnificent seven in Canada? Clayton
Read Answer Asked by Clayton on January 16, 2024
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!